Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Pediatr Radiol ; 44(6): 713-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24577684

ABSTRACT

BACKGROUND: Langerhans cell histiocytosis is a rare disease that occurs mainly in children, and hepatic involvement is generally a poor prognostic factor. OBJECTIVE: To describe CT and MRI findings of hepatic involvement of Langerhans cell histiocytosis in children, especially the abnormal bile duct manifestation on magnetic resonance cholangiopancreatography (MRCP). MATERIALS AND METHODS: Thirteen children (seven boys, six girls; mean age 28.9 months) were diagnosed with disseminated Langerhans cell histiocytosis. They underwent CT (n = 5) or MRI (n = 4), or CT and MRI examinations (n = 4) to evaluate the liver involvement. RESULTS: Periportal abnormalities presented as band-like or nodular lesions on CT and MRI in all 13 children. The hepatic parenchymal lesions were found in the peripheral regions of the liver in seven children, including multiple nodules on MRI (n = 6), and cystic-like lesions on CT and MRI (n = 3). In 11 of the 13 children the dilatations of the bile ducts were observed on CT and MRI. Eight of the 13 children underwent MR cholangiopancreatography, which demonstrated stenoses or segmental stenoses with slight dilatation of the central bile ducts, including the common hepatic duct and its first-order branches. The peripheral bile ducts in these children showed segmental dilatations and stenoses. CONCLUSION: Stenosis of the central bile ducts revealed by MR cholangiopancreatography was the most significant finding of liver involvement in Langerhans cell histiocytosis in children.


Subject(s)
Cholangiopancreatography, Magnetic Resonance , Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Langerhans-Cell/diagnosis , Liver Diseases/diagnosis , Liver Diseases/etiology , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Biopsy , Child, Preschool , Diagnosis, Differential , Female , Humans , Infant , Male , Prognosis
2.
Transl Pediatr ; 12(5): 927-937, 2023 May 30.
Article in English | MEDLINE | ID: mdl-37305710

ABSTRACT

Background: This study sought to analyze the clinical characteristics, biochemical metabolic indications, treatment results, and genetic spectrum of cerebral creatine deficiency syndrome (CCDS), estimate the prevalence of CCDS in Chinese children and provide a reference to guide clinical practice. Methods: We performed a retrospective cohort study of 3,568 children with developmental delay at Children's Hospital of Fudan University over a 6-year period (January 2017-December 2022). Metabolites in the blood/urine were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and genetic testing was performed by next-generation sequencing (NGS). The patients with suspected CCDS were ultimately diagnosed by magnetic resonance spectroscopy (MRS). The patients were then treated and followed up. All the reported cases of CCDS, their gene mutations, and treatment results in China were summarized. Results: Ultimately, 14 patients were diagnosed with CCDS. The age of onset was between 1-2 years. All the patients had developmental delay, 9 had epilepsy, and 8 had movement or behavioral disorders. A total of 17 genetic variants were identified, including 6 novel variants. c.403G>A, c.491dupG of the guanidinoacetate methyltransferase (GAMT) gene had a relatively high frequency. After treatment, patients with GAMT deficiency showed obvious improvements, and brain creatine (Cr) levels recovered to 50-80% of normal, 1 patient achieved normal neurodevelopment, and 3 patients became epilepsy free; however, 6 male patients with X-linked creatine transporter gene (SLC6A8) variants received Cr for 3-6 months with no effect, and 2 patients received combined therapy with few improvements. Conclusions: The prevalence of CCDS is ~0.39% in Chinese children with developmental delay. A low-protein diet, Cr and, ornithine were useful for patients with GAMT deficiency. Male patients with SLC6A8 deficiency showed only limited improvement on combined therapy.

3.
Sci Rep ; 11(1): 2005, 2021 01 21.
Article in English | MEDLINE | ID: mdl-33479468

ABSTRACT

Diagnosis of pediatric paragonimiasis is difficult because of its non-specific clinical manifestations. We retrospectively reviewed the records of pediatric paragonimiasis in Children's Hospital of Fudan University from January 2011 to May 2019. The confirmed diagnosis of paragonimiasis was based on positive anti-parasite serological tests from the local Center for Disease Control (CDC). A total of 11 patients (mean age: 7.7 ± 3.1, male-female ratio: 7:4) diagnosed as paragonimiasis were included. 81.8% were from endemic areas such as Sichuan and Yunnan, and 36% had a clear history of raw crab or crayfish consumption. The characteristic clinical features of pediatric paragonimiasis were eosinophilia (100%), pleural effusion (81.8%), hepatomegaly (54.5%), ascites (54.5%), and subcutaneous nodules (45.5%). Misdiagnosed with other diseases including tuberculosis (18.2%), pneumonia (9.1%), intracranial space-occupying lesions (9.1%) and brain abcess (9.1%) led to rehospitalization and prolonged hospitalization. For treatment, a 3-day course of 150 mg/kg praziquantel (PZQ) didn't show ideal treatment effectivity and 63.6% needed more than one course of PZQ, while triclabendazole in a total dose of 10 mg/kg had a better efficacy to stubborn manifestations. This study indicated that pediatric paragonimiasis was often misdiagnosed, and the treatment with a 3-day course of 150 mg/kg PZQ had a high rate of failure.


Subject(s)
Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/epidemiology , Paragonimiasis/diagnosis , Paragonimiasis/epidemiology , Animals , Anthelmintics/therapeutic use , Child , Child Health , China/epidemiology , Diagnosis, Differential , Diagnostic Errors , Female , Hospitals , Humans , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/parasitology , Male , Paragonimiasis/drug therapy , Paragonimiasis/parasitology , Paragonimus/pathogenicity , Pleural Effusion , Praziquantel/therapeutic use , Retrospective Studies , Risk Factors
4.
Article in English | MEDLINE | ID: mdl-17267277

ABSTRACT

The spectrophotometric titration by sodium hydroxide of 5,10,15-triphenyl-20-(4-hydroxyphenyl)porphyrin ((OH)(1)PH(2)) is studied as a function of solvent composition of DMF-H(2)O binary solvent mixture ([OH(-)]=0.04 M). Combining the structure changes of the porphyrin and the "four orbital" model of Gouterman, many features of the optical spectra of this deprotonated para-hydroxy-substituted tetraphenylporphyrin in different composition of binary solvent mixtures can be rationalized. In highly aqueous solvents, the changes of the titration curves are shown to be mainly due to hydrogen-bonding of the oxygen of the phenoxide anion group by the hydroxylic solvent, Which decreases the energy of the phenoxide anion pi orbital. Thus the phenoxide anion pi orbital cannot cross over the porphyrin pi orbital being a different HOMO. However, its energy is close to that of the porphyrin pi orbitals. As a result, in the visible region, no charge-transfer band is observed, while in the visible-near region, the Soret peak split into two components. In nonaqueous solvents, the changes are mainly attributed to further deprotonation of pyrrolic-Hs of (OH)(1)PH(2) by NaOH and coordination with two sodium ions to form the sodium complex of (OH)(1)PH(2), which turns hyperporphyrin spectra of deprotonated of phenolic-H of (OH)(1)PH(2) into three-banded spectra of regular metalloporphyrin.


Subject(s)
Dimethylformamide/analogs & derivatives , Porphyrins/chemistry , Dimethylformamide/chemistry , Models, Molecular , Molecular Conformation , Solvents , Spectrophotometry , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , Water
5.
J Phys Chem B ; 110(1): 587-94, 2006 Jan 12.
Article in English | MEDLINE | ID: mdl-16471571

ABSTRACT

Sequential deprotonations of meso-(p-hydroxyphenyl)porphyrins (p-OHTPPH2) in DMF + H2O (V/V = 1:1) mixture have been verified to result in the appearance of hyperporphyrin spectra. However, when the deprotonations of these p-OHTPPH2 are carried out in DMF, the spectral changes differ considerably from those in the mixture mentioned above. At low [OH-], the optical spectra in the visible region are still considered to have characteristics of hyperporphyrin spectra. Further deprotonation at much higher basicity makes the optical spectra form three-banded spectra similar to those in the acidic solution. To clarify the molecular origins of these changes, UV-vis, resonance Raman (RR), proton nuclear magnetic resonance (1H NMR) experiments are carried out. Our data give evidence that p-OHTPPH2 in DMF can be further deprotonated of pyrrolic-H by higher concentrated NaOH, due to an aprotic medium like DMF effectively weakening the basicity of the porphyrin relative to that of the NaOH, and coordinates with two sodium ions (except the sodium ions that interact with the peripherial phenoxide anions) to form the sodium complexes of p-OHTPPH2 (Na2P, to lay a strong emphasis on the sodium ions that coordinate with the central nitrogen atom), which can be regarded as the porphyrin anions being perturbed by the sodium cations due to their highly ionic character. The negative centers generated by deprotonation of pyrrolic-H and phenolic-H are not thoroughly delocalized between the substituents and the porphyrin ring. Thus the negative centers generated by deprotonation of pyrrolic-H only act as electron-donating groups on the porphyrin pi system, and the negative charges of the phenoxide anion are also mainly localized on the peripheral substituents. As a result, the porphyrin pi orbitals cross over the phenoxide anion pi orbital and turn into HOMOs, which turns hyperporphyrin spectra of deprotonated phenolic-H of p-OHTPPH2 into three-banded spectra of regular metalloporphyrins.


Subject(s)
Models, Chemical , Porphyrins/chemistry , Sodium/chemistry , Dimethylformamide/chemistry , Magnetic Resonance Spectroscopy/methods , Molecular Structure , Sensitivity and Specificity , Spectrophotometry, Ultraviolet/methods , Spectrum Analysis, Raman/methods
SELECTION OF CITATIONS
SEARCH DETAIL